Loading...
XNAS
TNON
Market cap1mUSD
Jul 09, Last price  
0.23USD
1D
0.22%
1Q
-70.05%
IPO
-99.99%
Name

Tenon Medical Inc

Chart & Performance

D1W1MN
XNAS:TNON chart
P/E
P/S
0.43
EPS
Div Yield, %
Shrs. gr., 5y
271.93%
Rev. gr., 5y
145.95%
Revenues
4m
+20.35%
53,64043,820160,000691,0002,928,0003,277,0003,944,000
Net income
-13m
L-8.17%
-509,580-585,178-7,048,000-18,917,000-15,581,000-13,673,000-12,556,000
CFO
-11m
L+8.78%
-235,203-167,363-4,292,000-12,025,000-12,183,000-9,878,000-10,745,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
IPO date
Apr 27, 2022
Employees
22
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT